Trump administration to let compounding pharmacies make six unapproved peptides
HHS will allow small compounding pharmacies to make six peptides without FDA approval, though production may not meet demand, NPR reports.
AI-written summary · The Chestnut Post · · How we use AI
The Trump administration will allow small compounding pharmacies to produce six peptides that have not been approved by the Food and Drug Administration, according to NPR.
The Department of Health and Human Services' move will permit production of the popular peptides, but it may not be enough to satisfy demand.
Originally reported by NPR. Read the full story at NPR
